Impact of therapeutic audit on phenytoin prescribing
- PMID: 6784817
- PMCID: PMC1505386
- DOI: 10.1136/bmj.282.6272.1278
Impact of therapeutic audit on phenytoin prescribing
Similar articles
-
Serum-phenytoin levels in management of epilepsy.Lancet. 1975 Aug 9;2(7928):247-8. doi: 10.1016/s0140-6736(75)90962-9. Lancet. 1975. PMID: 49797
-
Subtherapeutic levels of phenytoin with standard doses in infants: need to review dosage schedule.Br J Clin Pharmacol. 1999 Sep;48(3):465-6. Br J Clin Pharmacol. 1999. PMID: 10576792 No abstract available.
-
Fluctuations of plasma phenytoin levels on single dose and twice daily dose regimes.Proc Aust Assoc Neurol. 1975;12:61-4. Proc Aust Assoc Neurol. 1975. PMID: 1215397
-
The medical treatment of epilepsy: maintenance of drug therapy.Pediatr Ann. 1979 Apr;8(4):232-54. Pediatr Ann. 1979. PMID: 379769 Review. No abstract available.
-
[Oral loading dose of phenytoin].Rev Med Chil. 1988 Nov;116(11):1162-6. Rev Med Chil. 1988. PMID: 3077203 Review. Spanish. No abstract available.
Cited by
-
Drug treatment of epilepsy. Outlines, criticism and perspectives.Drugs. 1986 Mar;31(3):249-65. doi: 10.2165/00003495-198631030-00003. Drugs. 1986. PMID: 3519174 Review.
-
Early prognosis of epilepsy. Effects of treatment in the first follow-up year.Ital J Neurol Sci. 1986 Aug;7(4):421-9. doi: 10.1007/BF02283020. Ital J Neurol Sci. 1986. PMID: 3759415
-
The value of therapeutic drug monitoring to the practising physician--an hypothesis in need of testing.Br J Clin Pharmacol. 1989 Mar;27(3):281-4. doi: 10.1111/j.1365-2125.1989.tb05365.x. Br J Clin Pharmacol. 1989. PMID: 2719892 Free PMC article. No abstract available.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources